Cargando…
The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
Prostate cancer is one of the major cancers of the genitourinary tract. High-mobility group box 1 (HMGB1) was suggested as a promising therapeutic target for prostate cancer. In this study, we aim to elucidate the associations of HMGB1 single nucleotide polymorphisms (SNPs) with prostate cancer susc...
Autores principales: | Chou, Ying-Erh, Yang, Po-Jen, Lin, Chia-Yen, Chen, Yen-Yu, Chiang, Whei-Ling, Lin, Pei-Xuan, Huang, Zih-Yun, Huang, Matthew, Ho, Yung-Chuan, Yang, Shun-Fa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579148/ https://www.ncbi.nlm.nih.gov/pubmed/33023053 http://dx.doi.org/10.3390/ijerph17197247 |
Ejemplares similares
-
The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021) -
CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014) -
Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics
por: Hung, Sheng-Chun, et al.
Publicado: (2018) -
The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan
por: Chang, Li-Wen, et al.
Publicado: (2023) -
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)